Table 1.
Geneb | TSI vs C |
TS vs C |
Inflamed vs noninflamed |
|||
---|---|---|---|---|---|---|
FC | P | FC | P | FC | P | |
S100A7 | 5.54 | <0.0001 | 3.2 | <0.0001 | 1.3 | 0.11 |
SAA1 | 4.99 | <0.0001 | 2.11 | <0.0001 | 1.6 | 0.04 |
DEFB4A | 4.72 | <0.0001 | 1.42 | 0.01 | 2.46 | <0.0001 |
CXCL5 | 3.89 | <0.0001 | 1.18 | 0.43 | 3.4 | <0.0001 |
MMP12 | 3.55 | <0.0001 | 1.74 | <0.0001 | 1.62 | 0.0002 |
INDO | 3.29 | <0.0001 | 1.5 | <0.0001 | 1.96 | <0.0001 |
MMP9 | 3.06 | <0.0001 | 1.76 | <0.0001 | 1.67 | <0.0001 |
IL1B | 2.57 | <0.0001 | 1.59 | <0.0001 | 1.48 | 0.0003 |
NOS2 | 2.16 | <0.0001 | 1.27 | 0.005 | 1.38 | 0.007 |
MMP7 | 2.14 | <0.0001 | 1.23 | 0.003 | 1.51 | <0.0001 |
CD83 | 1.9 | <0.0001 | 1.4 | <0.0001 | 1.31 | 0.0004 |
IL13RA2 | 1.62 | 0.006 | 1.38 | 0.008 | 1.08 | 0.65 |
IL12B | 1.52 | 0.02 | 1.29 | 0.04 | 1.22 | 0.23 |
TNFA | 1.47 | <0.0001 | 1.14 | 0.008 | 1.23 | 0.003 |
IL-10 | 1.46 | 0.2 | 0.64 | 0.03 | 1.27 | 0.42 |
TIMP1 | 1.46 | <0.0001 | 1.4 | <0.0001 | 0.93 | 0.3 |
IFNG | 1.42 | 0.001 | 1.06 | 0.4 | 1.41 | 0.002 |
ARG1 | 1.3 | 0.01 | 1.25 | 0.0003 | 1.04 | 0.64 |
IL-13 | 1.22 | 0.3 | 1.17 | 0.19 | 1.09 | 0.64 |
CFH | 0.75 | <0.0001 | 1.13 | 0.005 | 0.68 | <0.0001 |
MMP1 | 0.58 | 0.009 | 1.28 | 0.05 | 0.63 | 0.02 |
MMP10 | 0.38 | <0.0001 | 0.86 | 0.02 | 0.54 | <0.0001 |
SPARCL1 | 0.06 | <0.0001 | 0.51 | <0.0001 | 0.19 | <0.0001 |
TSI versus C and TS versus C values were adjusted for age and sex. Inflamed versus noninflamed values were adjusted for age, sex, and level of clinical scarring. Using a Bonferroni correction for 69 comparisons, a P value of <0.0007 would be considered significant. See the text for discussion. TSI, trachomatous scarring with inflammation; TS, trachomatous scarring without inflammation; FC, fold change.
S100A7 = S100 calcium binding protein A7; SAA1 = serum amyloid A1; DEFB4A = defensin, beta 4A; CXCL5 = chemokine (C-X-C motif) ligand 5; MMP12 = matrix metalloproteinase 12; INDO = indoleamine-2,3-dioxygenase; MMP9 = matrix metalloproteinase 9; IL1B = interleukin-1; NOS2 = nitric oxide synthase 2, inducible; MMP7 = matrix metalloproteinase 7; CD83 = CD83 molecule; IL13RA2 = interleukin 13 receptor, alpha 2; IL12B = interleukin-12β; TNFA = tumor necrosis factor, alpha/beta; IL-10 = interleukin 10; TIMP1 = TIMP (tissue inhibitor of matrix metalloproteinase) matrix metalloproteinase inhibitor 1; IFNG = interferon gamma; ARG1 = arginase, liver; IL-13 = interleukin-13; CFH = complement factor H; MMP1 = matrix metalloproteinase 1; MMP10 = matrix metalloproteinase 10; SPARCL1 = SPARC (secreted protein, acidic, cysteine-rich)-like 1 (hevin).